info:eu-repo/semantics/article
Immunobiotic Lactobacillus rhamnosus improves resistance of infant mice against respiratory syncytial virus infection
Registro en:
Eriko, Chiba; Tomosada, Yohsuke; Vizoso Pinto, María Guadalupe; Salva, Maria Susana; Takahashi, Takuya; et al.; Immunobiotic Lactobacillus rhamnosus improves resistance of infant mice against respiratory syncytial virus infection; Elsevier Science; International Immunopharmacology; 17; 2; 10-2013; 373-382
1567-5769
Autor
Eriko, Chiba
Tomosada, Yohsuke
Vizoso Pinto, María Guadalupe
Salva, Maria Susana
Takahashi, Takuya
Tsukida, Kohichiro
Kitazawa, Haruki
Alvarez, Gladis Susana
Villena, Julio Cesar
Resumen
Previously we showed that orally administered Lactobacillus rhamnosus CRL1505 beneficially regulated the balance between pro- and anti-inflammatory mediators in the lungs of poly(I:C)-challenged mice, allowing an effective inflammatory response against the TLR3/RIG-I agonist but at the same time reducing tissue damage. The aim of the present study was to investigate whether oral administration of the CRL1505 strain was able to improve resistance against respiratory syncytial virus (RSV) infection in infant mice and to evaluate the immunological mechanisms involved in the immunobiotic effect. We demonstrated that treatment of 3-week old BALB/c mice with L. rhamnosus CRL1505 significantly reduce lung viral loads and tissue injuries after the challenge with RSV. Moreover, we showed that the protective effect achieved by the CRL1505 strain is related to its capacity to differentially modulate respiratory antiviral immune response. Our results shows that IFN-γ and IL-10 secreted in response to L. rhamnosus CRL1505 oral stimulation would modulate the pulmonary innate immune microenvironment conducting to the activation of CD103+ and CD11bhigh dendritic cells and the generation of CD3+CD4+IFN-γ+ Th1 cells with the consequent attenuation of the strong and damaging Th2 reactions associated with RSV challenge. Our results indicate that modulation of the common mucosal immune system by immunobiotics could favor protective immunity against respiratory viral pathogens with a high attack rate in early infancy, such as RSV. Fil: Eriko, Chiba. Tohoku University; Japón Fil: Tomosada, Yohsuke. Tohoku University; Japón Fil: Vizoso Pinto, María Guadalupe. Universidad Nacional de Tucuman. Facultad de Medicina. Departamento Biomedico. Laboratorio de Fisiologia y Farmacologia Vascular; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico - CONICET - Tucumán. Instituto Superior de Investigaciones Biológicas; Argentina Fil: Salva, Maria Susana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Tucumán. Centro de Referencia para Lactobacilos (i); Argentina Fil: Takahashi, Takuya. Tohoku University; Japón Fil: Tsukida, Kohichiro. Tohoku University; Japón Fil: Kitazawa, Haruki. Tohoku University; Japón Fil: Alvarez, Gladis Susana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Tucumán. Centro de Referencia para Lactobacilos (i); Argentina. Universidad Nacional de Tucumán. Facultad de Bioquímica, Química y Farmacia. Instituto de Bioquímica Clínica Aplicada; Argentina Fil: Villena, Julio Cesar. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Tucumán. Centro de Referencia para Lactobacilos (i); Argentina